Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001493152-16-016104)

Filing Details

Accession Number:: 0001493152-16-016104
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2016-12-21 16:04:40
Reporting Period:: 2016-12-19

Filing Date:: 2016-12-21
Accepted Time:: 2016-12-21 16:04:40
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1360214	Imprimis Pharmaceuticals Inc.	IMMY	()	4

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1242177	Md L Richard Lindstrom	C/O Imprimis Pharmaceuticals, Inc. 12264 El Camino Real, Suite 350 San Diego CA 92130		Yes	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2016-12-19	100,000	$1.79	100,000	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Purchase Warrant	Acquisiton	2016-12-19	100,000	$0.13	100,000	$1.79

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
100,000	2016-06-23	2019-12-23	No	4	P	Direct

Footnotes

On December 19, 2016 Dr. Lindstrom entered into a definitive agreement to acquire 100,000 Units of Imprimis Pharmaceuticals, Inc.'s (the "Company"), with each Unit consisting of one share of common stock, and a warrant to purchase one share of the Company's common stock, as part of a private placement by the Company to accredited investors.
The value of the Purchase Warrant included in each Unit is $0.125.